Date: 2013-03-11
Type of information: Grant
Company: Oncodesign (France)
Investors: Investing for the Future program (France)
Amount: € 13.4 million
Funding type: grant
Planned used:
Others: The IMODI (Innovative MODels Initiative) project will receive € 13.4 million in funding under the French Government\'s Investing for the Future program. The IMODI research project is designed to make the selection of new effective treatments to combat eight cancer pathologies easier. The aim of this national initiative is to pool the resources allocated to the development, profiling and evaluation of more than 200 predictive experimental cancer models and a wide range of derivative biological products and tests for molecular selection.
The project also plans to create a centralized biobank with more than 40,000 biological samples and powerful data analysis tools designed to identify tumor and immunological biomarkers, as well as those coming from the microbiome. Under the management and coordination of Oncodesign, the seven year project brings together six industrial groups (Sanofi, Servier, Ipsen, Pierre Fabre, Transgene and Biofortis), four SMEs (Oncomedics, Ariana Pharma, CTI BIOTECH and Oncodesign) and seven French institutions (Inserm [the French National Institute of Health and Medical Research], CNRS, [the French National Center for Scientific Research], the Georges Francois Leclerc Center in Dijon, the Leon Berard Center in Lyon for cancer research and treatment, Synergie Lyon Cancer, the University of Strasbourg and Toulouse University Hospital). Each organization belongs to one of five competitiveness clusters with authority to certify projects:
Medicen, for the Paris Region, Alsace Biovalley, Lyonbiopole, Atlanpole Biotherapies in Nantes and Cancer-Bio-Sante in Toulouse.
IMODI won the investment for the \'Focal-Point Research and Development Projects for Competitiveness Clusters\'. It will benefitfrom this funding after the final signing with OSEO. These subsidies and reimbursable advances will be allocated between the project\'s French institutions and financed partner SMEs. IMODI\'s forecasted overall investment budget of € 41 million also includes private investment. Over the next ten years the project will create 350 jobs within the partner companies.
Therapeutic area: Cancer - Oncology
